Phase 1/2 Clinical Trial Results Positive
-
Biologics
Phase 1/2 Clinical Trial Results Positive for SpinalCyte’s CybroCell™ Dermal Fibroblasts
February 13, 2018 HOUSTON–(BUSINESS WIRE)–Degenerative disc disease has long been considered an inevitable part of aging, but new breakthrough research…
Read More »